Quantum Biopharma Ltd. (QNTM) SEC Filings — 2024

Filings

• Quantum Biopharma Ltd. Files 6-K Report — 6-K · Dec 20, 2024
• Quantum Biopharma Ltd. Files November 2024 6-K Report — 6-K · Nov 25, 2024
• Quantum Biopharma Ltd. Q3 2024 Filing — 6-K · Nov 12, 2024
• Quantum Biopharma Ltd. Files October 2024 6-K Report — 6-K · Oct 29, 2024
• Quantum Biopharma Ltd. Files October 2024 6-K Report — 6-K · Oct 22, 2024
• Quantum BioPharma Ltd. Files 6-K, Incorporates Press Release — 6-K · Oct 21, 2024
• Quantum BioPharma Ltd. Files 6-K with SEC — 6-K · Oct 7, 2024
• Quantum BioPharma Ltd. Files September 2024 6-K — 6-K · Sep 30, 2024
• Quantum Biopharma Files 6-K, Incorporates Press Release — 6-K · Sep 16, 2024
• Quantum Biopharma Ltd. Files 6-K, Incorporates Press Release — 6-K · Sep 9, 2024
• Quantum Biopharma Files 6-K, Incorporates Press Release — 6-K · Aug 30, 2024
• Quantum Biopharma Ltd. Files 6-K, Incorporates F-3 Registration — 6-K · Aug 27, 2024
• Quantum Biopharma Ltd. Files 6-K, Incorporates Press Release — 6-K · Aug 26, 2024
• Quantum Biopharma Ltd. Files 6-K, Incorporates Exhibit — 6-K · Aug 16, 2024
• FSD Pharma Inc. Changes Name to Quantum BioPharma Ltd. — 6-K · Aug 15, 2024
• FSD Pharma Inc. Files 6-K, Incorporates into F-3 — 6-K · Aug 14, 2024
• FSD Pharma Inc. Announces Share Consolidation and Name Change — 6-K · Aug 12, 2024
• FSD Pharma Inc. Files 6-K Update — 6-K · Aug 9, 2024
• FSD Pharma Inc. Files 6-K on Shareholder Meeting Results — 6-K · Jul 30, 2024
• FSD Pharma Files Material Change Report Update — 6-K · Jul 8, 2024
• FSD Pharma Inc. Files 6-K with Corporate Updates — 6-K · Jun 28, 2024
• FSD Pharma's COVID-19 Drug Candidate Gets Ethics Approval — 6-K · Jun 27, 2024
• FSD Pharma Inc. Files 6-K, Announces Exclusive Agreement — 6-K · Jun 13, 2024
• FSD Pharma Inc. Files 6-K, Announces "Institutional" Approval — 6-K · Jun 4, 2024
• FSD Pharma Wins Petition to Confirm Restructuring Plan — 6-K · May 31, 2024
• FSD Pharma Submits Clinical Trial to Health Canada — 6-K · May 28, 2024
• FSD Pharma Files 6-K Corporate Update — 6-K · May 24, 2024
• FSD Pharma Inc. Files 6-K Update — 6-K · May 16, 2024
• FSD Pharma Files 6-K with Financial Statements — 6-K · May 15, 2024
• FSD Pharma Submits Phase 1 Trial Application for FSD-C101 — 6-K · May 7, 2024
• FSD Pharma Files 6-K, Announces Agreement — 6-K · Apr 30, 2024
• FSD Pharma Inc. Files 6-K Update — 6-K · Apr 25, 2024
• FSD Pharma Inc. Files 6-K With April Update — 6-K · Apr 22, 2024
• FSD Pharma Files 6-K, Expands Investigative Pipeline — 6-K · Apr 17, 2024
• FSD Pharma Files Year-End Results — 6-K · Apr 16, 2024
• FSD Pharma Inc. Files 6-K Update — 6-K · Apr 15, 2024
• FSD Pharma Inc. Files Form 6-K — 6-K · Apr 9, 2024
• FSD Pharma Inc. Files 20-F Report for Fiscal Year Ended December 31, 2023 — 20-F · Apr 2, 2024
• FSD Pharma Inc. Signs Agreement — 6-K · Mar 27, 2024
• FSD Pharma Files 6-K, Submits Phase-1b Clinical Trial Application — 6-K · Mar 11, 2024
• FSD Pharma Reports Positive Phase 1 Results for FSD201 — 6-K · Mar 5, 2024
• FSD Pharma Settles Debt, Files 6-K Report — 6-K · Feb 28, 2024
• FSD Pharma Inks Agreement with Inge, CFO Coyle Signs 6-K — 6-K · Feb 26, 2024
• FSD Pharma Updates on Razi Bokhari Litigation — 6-K · Feb 22, 2024
• FSD Pharma Announces US ATM Offering — 6-K · Feb 20, 2024
• FSD Pharma Launches $10M At-The-Market Offering — 6-K · Feb 20, 2024
• FSD Pharma Wins $3M Legal Battle Against Former Exec Bokhari — 6-K · Feb 7, 2024
• FSD Pharma Litigation with GBB Drink Lab Proceeds to Discovery — 6-K · Jan 16, 2024